These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30305806)

  • 1. stpm2cr: A flexible parametric competing risks model using a direct likelihood approach for the cause-specific cumulative incidence function.
    Mozumder SI; Rutherford MJ; Lambert PC
    Stata J; 2017; 17(2):462-489. PubMed ID: 30305806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct likelihood inference on the cause-specific cumulative incidence function: A flexible parametric regression modelling approach.
    Mozumder SI; Rutherford M; Lambert P
    Stat Med; 2018 Jan; 37(1):82-97. PubMed ID: 28971494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating restricted mean survival time and expected life-years lost in the presence of competing risks within flexible parametric survival models.
    Mozumder SI; Rutherford MJ; Lambert PC
    BMC Med Res Methodol; 2021 Mar; 21(1):52. PubMed ID: 33706711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The estimation and modelling of cause-specific cumulative incidence functions using time-dependent weights.
    Lambert PC
    Stata J; 2017 Mar; 17(1):181-207. PubMed ID: 30542252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine-Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1.
    Austin PC; Steyerberg EW; Putter H
    Stat Med; 2021 Aug; 40(19):4200-4212. PubMed ID: 33969508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flexible parametric modelling of the cause-specific cumulative incidence function.
    Lambert PC; Wilkes SR; Crowther MJ
    Stat Med; 2017 Apr; 36(9):1429-1446. PubMed ID: 28008649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods of competing risks flexible parametric modeling for estimation of the risk of the first disease among HIV infected men.
    Nouri S; Mahmoudi M; Mohammad K; Mansournia MA; Yaseri M; Akhtar-Danesh N
    BMC Med Res Methodol; 2020 Jan; 20(1):17. PubMed ID: 31996148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the adjusted cause-specific cumulative probability using flexible regression models for the cause-specific hazards.
    Kipourou DK; Charvat H; Rachet B; Belot A
    Stat Med; 2019 Sep; 38(20):3896-3910. PubMed ID: 31209905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort Study.
    Zelic R; Zugna D; Bottai M; Andrén O; Fridfeldt J; Carlsson J; Davidsson S; Fiano V; Fiorentino M; Giunchi F; Grasso C; Lianas L; Mascia C; Molinaro L; Zanetti G; Richiardi L; Pettersson A; Akre O
    Am J Epidemiol; 2019 Jun; 188(6):1165-1173. PubMed ID: 30976789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct likelihood inference and sensitivity analysis for competing risks regression with missing causes of failure.
    Moreno-Betancur M; Rey G; Latouche A
    Biometrics; 2015 Jun; 71(2):498-507. PubMed ID: 25761785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival analysis in the presence of competing risks.
    Zhang Z
    Ann Transl Med; 2017 Feb; 5(3):47. PubMed ID: 28251126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flexible parametric modelling of cause-specific hazards to estimate cumulative incidence functions.
    Hinchliffe SR; Lambert PC
    BMC Med Res Methodol; 2013 Feb; 13():13. PubMed ID: 23384310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis for aggregated survival data with competing risks: a parametric approach using cumulative incidence functions.
    Bonofiglio F; Beyersmann J; Schumacher M; Koller M; Schwarzer G
    Res Synth Methods; 2016 Sep; 7(3):282-93. PubMed ID: 26387882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the choice of timescale for other cause mortality in a competing risk setting using flexible parametric survival models.
    Skourlis N; Crowther MJ; Andersson TM; Lambert PC
    Biom J; 2022 Oct; 64(7):1161-1177. PubMed ID: 35708221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parametric regression on cumulative incidence function.
    Jeong JH; Fine JP
    Biostatistics; 2007 Apr; 8(2):184-96. PubMed ID: 16636138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations of Competing Risks Analysis in Cardio-Oncology Studies:
    Li Y; Sun L; Burstein DS; Getz KD
    JACC CardioOncol; 2022 Sep; 4(3):287-301. PubMed ID: 36213358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved confidence intervals for a difference of two cause-specific cumulative incidence functions estimated in the presence of competing risks and random censoring.
    Scosyrev E
    Biom J; 2020 Oct; 62(6):1394-1407. PubMed ID: 32227361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Joint modeling of longitudinal and competing-risk data using cumulative incidence functions for the failure submodels accounting for potential failure cause misclassification through double sampling.
    Thomadakis C; Meligkotsidou L; Yiannoutsos CT; Touloumi G
    Biostatistics; 2023 Dec; 25(1):80-97. PubMed ID: 36331265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.
    Varadhan R; Weiss CO; Segal JB; Wu AW; Scharfstein D; Boyd C
    Med Care; 2010 Jun; 48(6 Suppl):S96-105. PubMed ID: 20473207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis and design of randomised clinical trials involving competing risks endpoints.
    Tai BC; Wee J; Machin D
    Trials; 2011 May; 12():127. PubMed ID: 21595883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.